Atlas Trials

Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery

Clinical trial NCT01127477 · COMPLETED

Trial details

NCT number
NCT01127477
Sponsor
Fresenius Kabi Japan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage
Start date
2010-05-01
Primary completion
2010-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.